A study published in Obesity Reviews found that these medications could help reduce the frequency of binge eating episodes in individuals with BED by promoting feelings of fullness and reducing the urge to overeat (Erlanson-Albertsson et al., 2015)
Mistake 6: giving up during the first month Many people expect immediate results
Compounded drug products are not FDA-approved, and the FDA does not evaluate their safety, effectiveness, or quality
Side Effects of Qsymia for Weight Loss The most common side effects, reported by 5% or more of patients, include: Paresthesia (tingling in hands, feet, or face), reported by about 20% of patients Dry mouth Insomnia , especially if taken later in the day Dizziness Constipation Taste changes , particularly with carbonated drinks Mood changes , including irritability or low mood Difficulty concentrating or brain fog with higher doses of topiramate Less common but more serious risks include: Increased heart rate Acute glaucoma (rare, but requires immediate discontinuation) Kidney stones Birth defects (Qsymia is in a Risk Evaluation and Mitigation Strategy or REMS program, due to teratogenicity risk) Qsymia should not be used during pregnancy, in patients with glaucoma, hyperthyroidism or those taking MAOIs
Rights and permissions About this article Cite this article Rork, J.F., Hawryluk, E.B